Class IICompletedD-0149-2021
Drug recall · December 23, 2020
Kollidon CL-M Crospovidone Ph.Eur.Type B recall
Why: Cross contamination: the excipient was found to be contaminated with theophylline.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Kollidon CL-M Crospovidone Ph.Eur.Type B, USP/NF, JP, micronized, packaged in 30 kg plastic drums, Manufacturer: BASF SE, Carl-Bosch-Strabe 38, 67056 Ludwigshafen, Germany, Co-Manufactured by Siegfried PharmaChemikalien Minden GmbH, D-32423 Minden
- Lots / codes
Batch # 18472036, 18472041.
- Quantity
- 4560 kg
- Company
- BASF Corporation, Florham Park, NJ
- Distribution
- USA Nationwide and Worldwide
- Initiated
- November 17, 2020 · Voluntary: Firm initiated
- Classified
- December 15, 2020
- Reported
- December 23, 2020
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.